Plain-English translation of NCT05530655 on ClinicalTrials.gov โ ยท Source last updated ยท Translation generated ยท How we translate trials
Read our Prostate Cancer research guide โPhase 1 โ Testing in a small group (usually 20โ80 people) to find a safe dose and watch for side effects.
This early-stage trial is testing whether lisinopril, a blood pressure medication, can help prevent urinary side effects in men with prostate cancer who are receiving radiation therapy. The study will determine the best dose of this medication and track how well it works to protect the urinary system during and after treatment.
Radiation therapy for prostate cancer can damage the bladder and urinary tract, causing painful or difficult urination that can last months or years. This study is exploring whether this medication might protect these tissues and reduce these side effects.
You likely qualify ifโฆ
You likely don't qualify ifโฆ
If you join this study, you will either receive the medication along with your radiation therapy or be in a comparison group receiving radiation alone. The research team will monitor your urinary symptoms and collect blood samples to measure how the medication affects specific markers in your body. You will need to attend regular appointments at the cancer center and be willing to complete follow-up visits to track any urinary side effects over time.
AI-generated summary from trial data ยท Aug 12, 2026 ยท Not medical advice
United States